About Genentech Clinical Trials
Genentech Clinical Trials is a resource with information in clear and understandable language about clinical trials where Roche/Genentech is doing research or supporting research conducted by others. This resource is intended for patients, their relatives, caregivers or doctors.
You will find information about:
What clinical trials are, why they’re important and what it’s like to participate in one
What risks and potential benefits clinical trials may have.
How Roche/Genentech conducts clinical trials.
For Roche/Genentech sponsored clinical trials* you will find:
Information about the clinical trial itself.
Where you can find participating hospitals.
Links to further clinical trial resources.
As of March 2019, this resource has also included information about clinical trials where Roche is a supporting collaborator. These clinical trials are not sponsored by Roche and are included on Genentech Clinical Trials only if the trial sponsor agrees to its inclusion. For a full list of clinical trials where Roche is either the sponsor or a supporting collaborator, please visit this link . (Please note: this link will take you to a full listing of trials where Roche is either the sponsor or a supporting collaborator)
This website is for informational purposes only and is not to serve as a diagnostic tool or to replace a physician’s advice. If you are participating in a Roche/Genentech sponsored trial and have questions about your treatment or otherwise about your participation in the clinical trial, please speak with the doctor or staff at your study center.
Further information on clinical trials can be found on www.clinicaltrials.gov.
© 2022 Genentech, Inc.
All rights reserved.
*Note:
All Roche/Genentech sponsored clinical trials that started after December 2015 that are available on clinicaltrials.gov, and that are not terminated, suspended or withdrawn
Roche/Genentech sponsored clinical trials that started before December 2015, are available on clinicaltrials.gov and are still ongoing or have a layperson summary available for them